FREE PREVIEW Log in or buy this issue to read the full article. AAFP members and paid subscribers get free access to all articles. Subscribe now.

FREE PREVIEW Subscribe or buy this issue. AAFP members and paid subscribers get free access to all articles.

Am Fam Physician. 2010 Aug 1;82(3):230.

In the article, “Management of COPD Exacerbations,” (March 1, 2010, page 607) the brand name for methylprednisolone administered intravenously was incorrectly listed as Depo-Medrol in the first sentence of the third paragraph in the right-hand column of page 609 and in the last column of Table 5 (page 611). The brand name that should have been listed for intravenous methylprednisolone is Solu-Medrol. Depo-Medrol is the brand name of the long-acting intramuscular formulation. The article has been corrected online.

Copyright © 2010 by the American Academy of Family Physicians.
This content is owned by the AAFP. A person viewing it online may make one printout of the material and may use that printout only for his or her personal, non-commercial reference. This material may not otherwise be downloaded, copied, printed, stored, transmitted or reproduced in any medium, whether now known or later invented, except as authorized in writing by the AAFP. Contact for copyright questions and/or permission requests.

Want to use this article elsewhere? Get Permissions

Article Tools

  • Print page
  • Share this page

Information From Industry

More in Pubmed

Navigate this Article